Nengwei Yu
Overview
Explore the profile of Nengwei Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fu J, Yu L, Yu Q, Yu N, Xu F, Li S
J Ginseng Res
. 2023 Mar;
47(2):274-282.
PMID: 36926615
Background: Ginsenoside compound K (CK) stimulated activation of the PI3K-Akt signaling is one of the major mechanisms in promoting cell survival after stroke. However, the underlying mediators remain poorly understood....
12.
Li S, Xu F, Yu L, Yu Q, Yu N, Fu J
Chin J Nat Med
. 2023 Mar;
21(2):127-135.
PMID: 36871980
Stigmasterol is a plant sterol with anti-apoptotic, anti-oxidative and anti-inflammatory effect through multiple mechanisms. In this study, we further assessed whether it exerts protective effect on human brain microvessel endothelial...
13.
Yang B, Guo L, Yang X, Yu N
BMC Neurol
. 2022 Dec;
22(1):493.
PMID: 36539740
Background: Posterior reversible encephalopathy syndrome (PRES) is a rare disease characterized by reversible subcortical vasogenic brain edema. Neuromyelitis optica spectrum disorder (NMOSD) is a frequent neurological autoimmune disease that is...
14.
Li S, Yu N, Xu F, Yu L, Yu Q, Fu J
J Ginseng Res
. 2022 Sep;
46(5):700-709.
PMID: 36090684
Background: Ginsenoside Rd is a natural compound with promising neuroprotective effects. However, the underlying mechanisms are still not well-understood. In this study, we explored whether ginsenoside Rd exerts protective effects...
15.
Huang H, Zheng H, Zhang D, Yu N, Hu J, Xie M, et al.
J Clin Neurosci
. 2020 Oct;
79:113-117.
PMID: 33070877
Background: This study aimed to explore ethnic differences of acute ischemic stroke (AIS) in patients' characteristics, management and outcome in Chinese population in an institutional retrospective study. Methods: Data of...
16.
Wang P, Yu N, Wang Y, Sun H, Yang Z, Zhou S
J Mater Chem B
. 2020 Apr;
6(1):112-124.
PMID: 32254199
Anticancer drug delivery encounters many biological barriers, including mucosal barriers, nonspecific uptake and intracellular drug resistance. Consequently, efficient delivery of therapeutic agents with nanocarriers to the target cell and controlled...
17.
Li X, Yang L, Yin J, Yu N, Ye F
J Clin Neurol
. 2019 Jul;
15(3):313-320.
PMID: 31286702
Background And Purpose: There are only a few cognitive screening tests for the Chinese-speaking population, and so this study aimed to validate the Chinese version of Addenbrooke's Cognitive Examination III...
18.
Si Y, Xiao X, Xiang S, Guo J, Yu N, Mo Q, et al.
Acta Neurol Scand
. 2019 Apr;
140(2):100-106.
PMID: 31032888
Objective: This study aimed to investigate the current condition of mortality-specific comorbidity among hospitalized patients with ischemic stroke. Methods: Five-year data of inpatients with ischemic stroke (IS) were extracted from...
19.
Yang L, Li X, Yin J, Yu N, Liu J, Ye F
J Geriatr Psychiatry Neurol
. 2019 Apr;
32(4):205-210.
PMID: 30987514
Background/aims: There are limited cognitive screening tests for the Chinese-speaking population. This study aimed to validate the Chinese version of the Mini-Addenbrooke's Cognitive Examination (M-ACE) for detecting mild cognitive impairment...
20.
Yuan X, Wang J, Wang D, Yang S, Yu N, Guo F
Curr Neurovasc Res
. 2019 Mar;
16(2):129-134.
PMID: 30907315
Objective: Previous studies have shown that the neuron-specific- enolase (NSE), S100B protein (S100B) and matrix metalloproteinase-9 (MMP9) are specific markers for studying cerebral injury. This study was aimed to demonstrate...